Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oil-based versus water-based contrast media for hysterosalpingography in infertile women
2018-004192-12Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ethiodized oil and iodixanol in female infertility, ovulation disorder and Tubal factor infertility (TFI) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Conception leading to live birth within 6 months. Started Jul 2019; status: active.
02
Drugs
ethiodized oiliodixanol
03
Conditions
female infertilityovulation disorderTubal factor infertility (TFI)
Beyond the preview
Go deeper on 2018-004192-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004192-12.